In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Jessica CeramellaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.ORCID 0000-0002-1386-3601 Camillo RosanoU.O. Proteomica e Spettrometria di Massa, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132 Genova, Italy.ORCID 0000-0003-2949-9215 Domenico IacopettaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.ORCID 0000-0001-5179-7118 Iméne Ben ToumiaU.O. Proteomica e Spettrometria di Massa, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132 Genova, Italy.ORCID 0000-0003-2194-8741 Leila Chekir-GhediraLaboratory of Bioactive Natural Substances and Biotechnology, Faculty of Dentistry of Monastir, University of Monastir, Monastir 5000, Tunisia.
Mouna MaatoukLaboratory of Bioactive Natural Substances and Biotechnology, Faculty of Dentistry of Monastir, University of Monastir, Monastir 5000, Tunisia.
Annaluisa MaricondaDepartment of Basic and Applied Sciences, University of Basilicata, Via dell'Ateneo Lucano, 10, 85100 Potenza, Italy.ORCID 0000-0002-9763-838X Pasquale LongoDepartment of Chemistry and Biology "A. Zambelli", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.ORCID 0000-0002-7685-1093 Patrick DallemagneUniversité Caen Normandie, Normandie University, CERMN UR4258, F-14000 Caen, France.ORCID 0000-0002-4845-615X Christophe RochaisUniversité Caen Normandie, Normandie University, CERMN UR4258, F-14000 Caen, France.ORCID 0000-0001-7996-2082 Maria Stefania SinicropiDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.ORCID 0000-0003-2435-8931 Funding
Italian Ministry of Health (funds "Ricerca Corrente") NAPRIN 2022, Code 2022HARH5W - HyMTA (Hybrid Multi-Target Agents) C53D23004490001
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anticancerapoptosiscarbazole derivativescytoskeletontoxicity studies
Identifiers
PMID40284411
PMCPMC12030284
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390